Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

被引:840
作者
Spiller, RC
Jenkins, D
Thornley, JP
Hebden, JM
Wright, T
Skinner, M
Neal, KR
机构
[1] Univ Nottingham Hosp, Div Gastroenterol, Nottingham NG7 2UH, England
[2] Univ Nottingham Hosp, Dept Pathol, Nottingham NG7 2UH, England
[3] Univ Nottingham Hosp, Dept Publ Hlth Med, Nottingham NG7 2UH, England
关键词
irritable bowel syndrome; Campylobacter; enteroendocrine cell; T lymphocytes;
D O I
10.1136/gut.47.6.804
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims-Post-dysenteric irritable bowel syndrome (PD-IBS) develops in up to 25% of patients following Campylobacter enteritis. Our aim was to define the pathological basis of this subgroup of IBS. Methods-Twenty one patients (group 1) underwent serial rectal biopsy and gut permeability testing following acute Campylobacter enteritis as did 10 PD-IBS patients (group 2) and 12 asymptomatic controls. Results-In group I, enteroendocrine cell (EC) numbers were markedly increased initially and at six and 12 weeks (p<0.001) compared with controls. Gut permeability, as assessed by the lactulose/mannitol ratio, was significantly elevated, initially and at 12 weeks (p<0.005). CD3, CD4, and CD8 lymphocyte counts in the lamina propria and intraepithelial lymphocytes (IEL) were significantly increased initially compared with controls. At visit 1, EC numbers were positively correlated with CD3 counts (r=0.6, p=0.01). At one year, seven subjects (five with persistent loose stools) had rectal biopsies which showed significantly elevated EC, CD3, and IEL counts. In group 2, EC and IEL counts were significantly increased compared with controls (p<0.001), as was gut permeability (p<0.01). Conclusion-Increased EC, T lymphocytes, and gut permeability are acute changes following Campylobacter enteritis which can persist for more than a year and may contribute to PD-IBS.
引用
收藏
页码:804 / 811
页数:8
相关论文
共 49 条
  • [1] HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY
    ADRIAN, TE
    FERRI, GL
    BACARESEHAMILTON, AJ
    FUESSL, HS
    POLAK, JM
    BLOOM, SR
    [J]. GASTROENTEROLOGY, 1985, 89 (05) : 1070 - 1077
  • [2] 5-hydroxytryptamine release into human jejunum by cholera toxin
    Bearcroft, CP
    Perrett, D
    Farthing, MJG
    [J]. GUT, 1996, 39 (04) : 528 - 531
  • [3] Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study
    Bearcroft, CP
    Perrett, D
    Farthing, MJG
    [J]. GUT, 1998, 42 (01) : 42 - 46
  • [4] 5-HT2 AND 5-HT3 RECEPTOR SUBTYPES MEDIATE CHOLERA TOXIN-INDUCED INTESTINAL FLUID SECRETION IN THE RAT
    BEUBLER, E
    HORINA, G
    [J]. GASTROENTEROLOGY, 1990, 99 (01) : 83 - 89
  • [5] PEPTIDE YY AUGMENTS POSTPRANDIAL SMALL-INTESTINAL ABSORPTION IN THE CONSCIOUS DOG
    BILCHIK, AJ
    HINES, OJ
    ZINNER, MJ
    ADRIAN, TE
    BERGER, JJ
    ASHLEY, SW
    MCFADDEN, DW
    [J]. AMERICAN JOURNAL OF SURGERY, 1994, 167 (06) : 570 - 574
  • [6] Brown DR, 1996, BEHAV BRAIN RES, V73, P193
  • [7] REGIONAL DIFFERENCES IN CONCENTRATIONS OF REGULATORY PEPTIDES IN HUMAN-COLON MUCOSAL BIOPSY
    CALAM, J
    GHATEI, MA
    DOMIN, J
    ADRIAN, TE
    MYSZOR, M
    GUPTA, S
    TAIT, C
    BLOOM, SR
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (08) : 1193 - 1198
  • [8] CHAUDHARY NA, 1962, Q J MED, V31, P307
  • [9] CHEN Y, 1998, MUCOSAL IMMUNOL UPDA, V6, P4
  • [10] INTESTINAL PERMEABILITY AND SCREENING-TESTS FOR CELIAC-DISEASE
    COBDEN, I
    ROTHWELL, J
    AXON, ATR
    [J]. GUT, 1980, 21 (06) : 512 - 518